Mechanisms and Implications of Age-Related Changes in the Liver: Nonalcoholic Fatty Liver Disease in the Elderly
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is hepatic steatosis associated with metabolic abnormalities such as overweight/central obesity, insulin resistance, type 2 diabetes (T2D), and dyslipidemia. NAFLD is becoming the most common liver disease in contemporary society, with the highest prevalence in those over 60 years. NAFLD pathology ranges from simple steatosis to a necroinflammatory fibrosing disorder called steatohepatitis (SH), the latter associated with high risk of developing cirrhosis, often occuring in the seventh to ninth decades of life. While the main health implications of NAFLD are increased risk of developing T2D, cardiovascular diseases, and common cancers, there is substantantially increased standardized mortality, and deaths from decompensated cirrhosis and hepatocellular carcinoma (HCC). Little is known about the interactive effects of ageing and NAFLD, with most studies focusing on the younger population. This paper summarises the epidemiology, pathogenesis, and clinical course of NAFLD, with particular attention to persons over age 60 years. An approach to the management of NASH and its complications in the elderly, will also be presented here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Mechanism of hepatic steatosis, adapted from Larter et al. 2010 [12], showing also interactions between adipose tissue in differing sites with liver in the development of insulin resistance (IR). FFA: free fatty acids; SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue; TG: triglyceride.](https://figures.cochat.ai/paper-figures/0dead70903384916b109d67f64dbc328/mechanisms-and-implications-of-age-related-changes-in-the-liver-nonalcoholic-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, with age, the decline in WAT mass is associated with accumulation of fat in ectopic regions in non-adipose tissue organs like skeletal muscle (34), liver (35), and bone marrow (36), which exacerbates metabolic dysfunction (37).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Angelico, F., Burattin, M., Alessandri, C., Del Ben, M., & Lirussi, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005166.pub2 · Cited by 114
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“As discussed earlier, the accompanying hyperinsulinemia promotes de novo hepatic lipogenesis [79], further promoting lipid overload in hepatocytes.”
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 1×
“Rosiglitazone has been withdrawn from the European market due to increased rates of myocardial infarction, but not overall cardiovascular mortality in a meta-analysis of approximately 35,000 patients from 56 randomised controlled trials [112].”
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 3×
“An older concept of NASH pathogenesis, the so-called “two-hit” hypothesis of Day and James [58], proposed that hepatocyte TG accumulation resulting from metabolic imbalance (obesity, IR and diabetes) is what leads to steatosis (the “first hit”) and that the lipid-laden liver is then vulnerable to injurious processes (…”
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“In the elderly population, TE is a promising noninvasive method of quantifying liver fibrosis in NAFLD.”
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“Kinetic studies indicate that approximately 75% of hepatic lipids (TAG/TG) in obese patients with NAFLD comes from peripheral sites (60% from nonesterified free fatty acids from lipolysis and 15% from diet), with approximately 25% arising from de novo lipogenesis [68].”
Research works printed but not linked: 1
- IDF The IDF consensus worldwide definition of the metabolic syndrome Metabolic Syndrome 2007 1 16
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
“Both autophagic and CMA activity are impaired with aging, leading to lipid accumulation in various organs, including the liver.310 Furthermore, the accumulation of damaged mitochondria is a hallmark of NASH.311 Mitophagy, a form of autophagy that selectively targets abnormal mitochondria for lysosomal degradation, is…”
BackgroundInfluentialMitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Nonalcoholic fatty liver disease and aging: epidemiology to management.
Bertolotti, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14185 · Cited by 270
Mak, K. M., & Mei, R. (2017) · The Anatomical Record · doi:10.1002/ar.23567 · Cited by 269
“Codistribution of Col IV and Laminin as a Marker of Perisinusoidal Basement Membrane Formation in Liver Fibrosis of Elderly Cadavers Fibrotic changes are often seen in aged livers (Gan et al., 2011; Noureddin et al., 2013; Xu et al., 2013).”
BackgroundLiver diseases and aging: friends or foes?
Sheedfar, F., Biase, S. D., Koonen, D., & Vinciguerra, M. (2013) · Aging Cell · doi:10.1111/acel.12128 · Cited by 248
“and there are only inconclusive data available on the progression ofNASH in the very elderly (Gan et al., 2011).”
BackgroundInfluentialMayo, R., Crespo, J., Martínez‐Arranz, I., Banales, J. M., Arias, M., Mincholé, I., Aller de la Fuente, R., Jimenez‐Agüero, R., Alonso, C., de Luis, D. A., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1188 · Cited by 164
“With regards to age, although several studies have been published highlighting the relationship between the prevalence of NASH and age,((46,47)) the average age was similar in the different stages of the disease for both cohorts.”
ResultWu, E. M., Wong, L. L., Hernandez, B. Y., Ji, J., Jia, W. P., Kwee, S. A., & Kalathil, S. C. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.87 · Cited by 166
“Males are overall more likely than females to have NAFLD/NASH, however, after the age of 60 years, females are much more likely to have NAFLD/NASH[9,10].”
BackgroundRisk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease
Sourianarayanane, A., Garg, G., Smith, T. H., Butt, M., McCullough, A. J., & Shen, B. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.10.015 · Cited by 160
MANF regulates metabolic and immune homeostasis in ageing and protects against liver damage
Sousa-Victor, P., Neves, J., Cedron-Craft, W., Ventura, P. B., Liao, C.-Y., Riley, R. R., Soifer, I., van Bruggen, N., Kolumam, G. A., Villeda, S. A., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0023-6 · Cited by 130
“The prevalence of metabolic syndrome and nonalcoholic fatty liver disease (NAFLD), ranging from liver steatosis to non-alcoholic steatohepatitis (NASH), increases with age 14,15 and pharmacologic approaches that reduce inflammation improve liver homeostasis 16 .”
Wang, X., Seo, Y. A., & Park, S. K. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111190 · Cited by 128
Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
Hu, X., Huang, Y., Bao, Z., Wang, Y., Shi, D., Liu, F., Gao, Z., & Yu, X. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-123 · Cited by 111
“the hepatic metabolism of LDL cholesterol, increases abdominal adiposity and fat deposition in muscles, liver, and bone marrow, resulting in deleterious metabolic consequences of IR [8].”
BackgroundThe Role of Autophagy for the Regeneration of the Aging Liver
Xu, F., Hua, C., Tautenhahn, H., Dirsch, O., & Dahmen, U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103606 · Cited by 88
“It leads to an increase in the size of hepatocytes, a decrease in the number of mitochondria and an increase in the number of binucleated cells [10,85].”
BackgroundLavdas, I., Rockall, A., Castelli, F., Sandhu, R. S., Papadaki, A., Honeyfield, L., Waldman, A. D., & Aboagye, E. O. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.13964 · Cited by 75
“6 and Table S2), although there is a difference in the fat content between men and women [23], as discussed earlier.”
BackgroundInfluentialHepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation
Cao, Y., Xue, Y., Xue, L., Jiang, X., Wang, X., Zhang, Z., Yang, J., Lu, J., Zhang, C. X., Wang, W., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.011 · Cited by 75
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
Lonardo, A., Mantovani, A., Petta, S., Carraro, A., Byrne, C. D., & Targher, G. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00711-5 · Cited by 74
Tobari, M., & Hashimoto, E. (2019) · Gut and Liver · doi:10.5009/gnl19236 · Cited by 71
“Histological examination reveals enlargement of hepatocytes, an increase of binucleated hepatocytes, and a decrease of mitochondria with aging.(65,66) Age is also a risk factor for hepatic steatosis due to the onset of multiple abnormalities of hepatic lipid metabolism.”
BackgroundSerum cytokeratin‐18 in the diagnosis of non‐alcoholic steatohepatitis: A meta‐analysis
Chen, J., Zhu, Y., Zheng, Q., & Jiang, J. (2014) · Hepatology Research · doi:10.1111/hepr.12197 · Cited by 48
Varela‐López, A., Pérez-López, M. P., Ramírez-Tortosa, C. L., Battino, M. A., Granados-Principal, S. M., Ramirez-Tortosa, M. D. C., Ochoa, J. J., Ramírez, L. V., Giampieri, F., & Quiles, J. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.007 · Cited by 48
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Raza, S., Rajak, S., Anjum, B., & Sinha, R. A. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.014 · Cited by 54
“Intriguingly, although males are more likely to develop both NAFLD and HCC than females, after the age of 60 this trend is reversed([122-124]).”
BackgroundRutin Attenuates Hepatotoxicity in High‐Cholesterol‐Diet‐Fed Rats
AlSharari, S. D., Al-Rejaie, S. S., Abuohashish, H. M., Ahmed, M. M. M., & Hafez, M. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5436745 · Cited by 47
“Nonalcoholic fatty liver disease can end in cirrhosis and hepatocellular carcinoma [6].”
BackgroundTschida, B. R., Temiz, N. A., Kuka, T. P., Lee, L. A., Riordan, J. D., Tierrablanca, C. A., Hullsiek, R., Wagner, S., Hudson, W. A., Linden, M. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2281 · Cited by 49
“(Supplementary Figure S1C) Hepatic steatosis increases with age in humans and mice,(29,30) and in ND-treated mice, FoxA1 expression significantly decreased with age (Pearson’s correlation coefficient, r, = −.”
BackgroundBullón‐Vela, V., Abete, I., Tur, J. A., Pintó, X., Corbella, E., Martínez‐González, M. Á., Toledo, E., Corella, D., Macías, M., Tinahones, F. J., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110620 · Cited by 51
Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis
Jadeja, R. N., & Devkar, R. V. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00047-5 · Cited by 52
Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver
Guaraldi, G., Lonardo, A., Maia, L. E. O., & Palella, F. J. (2017) · AIDS · doi:10.1097/qad.0000000000001483 · Cited by 47
Shi, C., de Wit, S., Učambarlić, E., Markousis‐Mavrogenis, G., Screever, E. M., Meijers, W. C., de Boer, R. A., & Aboumsallem, J. P. (2023) · Cancers · doi:10.3390/cancers15030729 · Cited by 55
Refeeding-associated AMPKγ1 complex activity is a hallmark of health and longevity
Ripa, R., Ballhysa, E., Steiner, J. D., Laboy, R., Annibal, A., Hochhard, N., Latza, C., Dolfi, L., Calabrese, C., Meyer, A. M., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00521-y · Cited by 48
Han, X., Bao, X., Lou, Q., Xie, X. M., Zhang, M., Zhou, S., Guo, H., Jiang, G., & Shi, Q. (2019) · PeerJ · doi:10.7717/peerj.7568 · Cited by 45
Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice
Fei, M., Sun, H., Wang, B., Ahmad, N., Guo, H., Gao, H., Gao, Y., Liu, X., & Li, H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173214 · Cited by 44
Wáng, Y. X. J., Huang, H., Zheng, C., Xiao, B., Chevallier, O., & Wang, W. (2021) · PubMed · Cited by 61
Mak, K. M., Chu, E. W., Lau, K. H. V., & Kwong, A. J. (2012) · The Anatomical Record · doi:10.1002/ar.22504 · Cited by 39
“Advancing age has been shown to accelerate liver injury and increase the severity of fibrosis associated with alcohol abuse, NAFLD/NASH and hepatitis C infection (Martin-Carbonero et al., 2004; Seitz and Stickel, 2007; Davis et al., 2010; Frith and Newton, 2010; Fox et al., 2011; Gan et al., 2011).”
BackgroundLoss of GPR109A/HCAR2 induces aging-associated hepatic steatosis
Jadeja, R. N., Jones, M. A., Fromal, O., Powell, F. L., Khurana, S., Singh, N., & Martin, P. M. (2019) · Aging · doi:10.18632/aging.101743 · Cited by 40
“The age-associated alteration of liver structure and function is supported by histologic findings such as hepatocyte enlargement, the presence of an increased number of binucleated cells, and reduced mitochondrial density that present with increased age even in the absence of disease [4, 5].”
Zamanian, H., Shalbaf, A., Zali, M. R., Khalaj, A. R., Dehghan, P., Tabesh, M. R., Hatami, B., Alizadehsani, R., Tan, R., & Acharya, U. R. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107932 · Cited by 37
Huang, H., Zheng, C., Wang, L., Che‐Nordin, N., & Wáng, Y. X. J. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4449 · Cited by 39
“Beyond menopause, the prevalence of fatty liver rises sharply in women and exceeds that observed in their male counterparts.(37) Using two-point mDIXON sequences at 3.”
BackgroundGoh, G. B., Pagadala, M. R., Dasarathy, J., Ünalp–Arida, A., Pai, R. K., Yerian, L. M., Khiyami, A., Sourianarayanane, A., Sargent, R., Hawkins, C., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3529-8 · Cited by 31
Global gene expression profile of normal and regenerating liver in young and old mice
Pibiri, M., Sulas, P., Leoni, V. P., Perra, A., Kowalik, M. A., Cordella, A., Saggese, P., Nassa, G., & Ravo, M. (2015) · AGE · doi:10.1007/s11357-015-9796-7 · Cited by 31
Kinoshita, A., Koike, K., & Nishino, H. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12747 · Cited by 29
Zhao, F., Zhou, N., Wang, J., Zhou, H., Zou, L.-Q., Zhong, W., He, J., Zheng, C., Yan, S., & Wáng, Y. X. J. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-651 · Cited by 29
“Beyond menopause, the prevalence of fatty liver rises sharply in women and may exceed that observed in their male counterparts (31-33).”
BackgroundRejuvenation: Turning Back Time by Enhancing CISD2
Yeh, C., Shen, Z., Lin, C.-C., Lu, C.-K., & Tsai, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214014 · Cited by 30
“NAFLD is the most common liver disease in society, with the highest prevalence being in those over 60 years old [53].”
BackgroundLee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Gender-specific liver aging and magnetic resonance imaging
Wáng, Y. X. J. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-227 · Cited by 26
“After the age of 60 years, females overtake their male counterparts in prevalence of NAFLD, with an age and gender distribution resembling that of cardiovascular disease (31-33) (Figure 5).”
BackgroundAging Induces Hepatic Oxidative Stress and Nuclear Proteomic Remodeling in Liver from Wistar Rats
Bárcena, B., Salamanca, A., Pintado, C., Mazuecos, L., Villar, M., Moltó, E., Bonzón‐Kulichenko, E., Vázquez, J., Andrés, A., & Gallardo, N. (2021) · Antioxidants · doi:10.3390/antiox10101535 · Cited by 25
“Even though the mechanisms of progression of NAFLD from simple steatosis to steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma have been extensively documented [7], it needs to be completely elucidated.”
BackgroundExploring the Prospective Role of Propolis in Modifying Aging Hallmarks
Scorza, C. A., Gonçalves, V., Finsterer, J., Scorza, F. A., & Fonseca, F. L. A. (2024) · Cells · doi:10.3390/cells13050390 · Cited by 29
“The prevalence of nonalcoholic fatty liver disease (NAFLD) is 39% among individuals aged 40 to 50 and exceeds 40% in those aged 70 and above [250].”
BackgroundFisher, L., Srikusalanukul, W., Fisher, A., & Smith, P. N. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10696 · Cited by 25
“all liver cells, accumulation of ageing pigments at the cytoplasm and pseudocapillarization of the sinusoid.(1-4) Over the past several years, substantial research has shown that alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) activities decrease with old age.”
BackgroundResultWang, A., Blackford, A. L., Behling, C. A., Wilson, L., Newton, K. P., Xanthakos, S. A., Fishbein, M. H., Vos, M. B., Mouzaki, M., Molleston, J. P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000644 · Cited by 24
Banini, B. A., & Sanyal, A. J. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2020.11.001 · Cited by 21
Wang, G., Wu, S., Wu, C., Zhang, Q., Wu, F., Yu, B., Zhang, S., Wu, C., Wu, G., & Zhong, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17042 · Cited by 22
Amini‐Salehi, E., Hassanipour, S., Joukar, F., Daryagasht, A. A., Khosousi, M., Aleali, M. S., Ansar, M. M., Heidarzad, F., Abdzadeh, E., Vakilpour, A., et al. (2023) · Hepatitis Monthly · doi:10.5812/hepatmon-131523 · Cited by 23
“Various factors are involved in the development of NAFLD, including genetic features (10), diet (11), physical activity (PA) (12), smoking (13), aging (14), obesity (15), dyslipidemia (16), and HTN (17).”
BackgroundRusli, F., Lute, C., Boekschoten, M. V., van Dijk, M., van Norren, K., Menke, A. L., Müller, M. M., & Steegenga, W. T. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600677 · Cited by 22
Is the liver resilient to the process of ageing?
Chatterjee, N., Sharma, R., Kale, P. R., Trehanpati, N., & Ramakrishna, G. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101580 · Cited by 27
“Yet another speci fi c age-related hepatic change is the increase in number of binucleated cell and reduction in mitochondrial number [29-30].”
Ulbrich, E. J., Fischer, M. A., Manoliu, A., Marcon, M., Luechinger, R., Nanz, D., & Reiner, C. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141691 · Cited by 23
Łysek-Gładysińska, M., Wieczorek, A., Jóźwik, A., Walaszczyk, A., Jelonek, K., Szczukiewicz-Markowska, G., Horbańczuk, O. K., Pietrowska, M., Widłak, P., & Gabryś, D. (2021) · Cells · doi:10.3390/cells10030502 · Cited by 21
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions
Pinto, C., Ninfole, E., Benedetti, A., Maroni, L., & Marzioni, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00332 · Cited by 18
Xu, J., Ni, S., Wang, Y., Yan, M., Yang, X., Ge, H., Jia, Z., Yang, Z. X., Shan, A., Liu, H., et al. (2022) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-022-01913-0 · Cited by 18
“Several studies suggested that higher age is associated with increased NAFLD prevalence and incidence (Bayrak 2020; Gan et al. 2011; Shima et al. 2015).”
BackgroundSalamanca, A., Bárcena, B., Arribas, C., Fernández‐Agulló, T., Martínez, C., Carrascosa, J. M., Ros, M., Andrés, A., & Gallardo, N. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.009 · Cited by 20
Particulate matter 2.5 accelerates aging: Exploring cellular senescence and age-related diseases
Wang, S., Shi, Y., Lin, S., & He, H.-F. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116920 · Cited by 24
Kepchia, D., Huang, L., Currais, A. J. M., Liang, Z., Fischer, W. H., & Maher, P. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112648 · Cited by 17
Senoinflammation as the underlying mechanism of aging and its modulation by calorie restriction
Noh, S. G., Kim, H., Kim, S., Chung, K. W., Jung, Y.-S., Yoon, J.-H., Yu, B. P., Lee, J., & Chung, H. Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102503 · Cited by 16
Wei, X., Murphy, M. A., Reddy, N. A., Hao, Y., Eggertsen, T. G., Saucerman, J. J., & Bochkis, I. M. (2022) · Genome Research · doi:10.1101/gr.277149.122 · Cited by 13
“Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in T2D (Portillo-Sanchez et al. 2015) and the elderly, impacting 40% of individuals over 70 (Gan et al. 2011).”
Liu, R., Xu, W., Zhu, H., Dong, Z., Dong, H., & Yin, S. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01014-6 · Cited by 12
“molecular biological changes, such as altered hepatocyte morphology, reduced mitochondrial quantity and quality, and an increased proportion of multinucleated cells [4, 5].”
BackgroundSpradley, F. T., Smith, J. A., Alexander, B. T., & Anderson, C. D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00394.2017 · Cited by 14
“sis within 10 yr and require transplantation (72, 179).”
BackgroundZhang, M., Wei, J., Sun, Y., He, C., Ma, S., Pan, X., & Zhu, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.008 · Cited by 16
“The primary distinguishing feature of NAFLD is fat in hepatocytes [141–144].”
Park, M., Hwang, S., Kang, H.-B., Ha, M., Park, J., Park, S.-Y., Park, Y. J., & Park, M.-H. (2025) · Cells · doi:10.3390/cells14020126 · Cited by 13
Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice
Luo, D., Li, J., Chen, K., Yin, Y., Fang, Z., Pang, H., Rong, X., & Guo, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00926 · Cited by 11
Advanced age heightens hepatic damage in a murine model of scald burn injury
Idrovo, J., Boe, D. M., Kaahui, S., Walrath, T., McMahan, R. H., & Kovacs, E. J. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003048 · Cited by 14
“The increase in lipid accumulation seen in aged animals after burn injury could be explained by the increased susceptibility of the aged liver to injury and/or poor regeneration, as observed in elderly individuals.(45) Aging is also associated with heightened oxidative stress and diminished tolerance to oxidative trau…”
BackgroundKim, Y., Kwon, O. K., Chae, S., Jung, H., Ahn, S. H., Jeon, J. M., Sung, E., Kim, S., Ki, S. H., Chung, K. W., et al. (2018) · PROTEOMICS · doi:10.1002/pmic.201700240 · Cited by 11
Mak, K. M., Sehgal, P., & Harris, C. K. (2014) · International Scholarly Research Notices · doi:10.1155/2014/839560 · Cited by 12
Hafez, S. M. N. A., & Elbassuoni, E. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108465 · Cited by 12
Rose, M., Veysey, M. J., Lucock, M. D., Niblett, S. H., King, K., Baines, S., & Garg, M. L. (2016) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2016.04.007 · Cited by 10
“Furthermore, it has also been reported that NAFLD is becoming more prevalent in the older population (>60 years) [6] with post-menopausal women more likely to develop NAFLD than men of the same age [6].”
BackgroundMuscle PGC-1α modulates hepatic mitophagy regulation during aging
Christensen, N. M., Ringholm, S., Buch, B. T., Gudiksen, A., Halling, J. F., & Pilegaard, H. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112046 · Cited by 9
“Aging is known to be associated with detrimental changes in many tissues, including sarcopenia with loss of muscle mass and reduced muscle strength, as well as decreased hepatic volume and hepatic steatosis (Frith et al., 2009; Gan et al., 2011; Lauretani et al., 2003; Ogrodnik et al., 2017).”
BackgroundLuckhoff, H. K., Kruger, F. C., & Kotze, M. J. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i9.1192 · Cited by 10
Dihydrocapsiate improved age-associated impairments in mice by increasing energy expenditure
Ohyama, K., & Suzuki, K. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00132.2017 · Cited by 9
“Hepatic changes associated with aging include increased hepatocyte size, a reduction in mitochondrial number, and lipid accumulation (18, 40, 41).”
BackgroundWiese, M. D., Meakin, A. S., Varcoe, T. J., Darby, J. R. T., Sarr, O., Kiser, P. K., Bradshaw, E. L., Regnault, T. R. H., & Morrison, J. L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120133 · Cited by 10
Proteomic and phosphoproteomic signatures of aging mouse liver
Mohallem, R., Schaser, A. J., & Aryal, U. K. (2025) · GeroScience · doi:10.1007/s11357-025-01601-0 · Cited by 8
“Oxidative stress due to aging leads to accumulation of products of lipid peroxidation [35] and also senescence-associated signaling such as p16, p21, and p53 [36].”
Nakajima, T., Nakashima, T., Yamaoka, J., Shibuya, A., Itoh, Y., & Yoshikawa, T. (2012) · Journal of Gastroenterology and Hepatology Research · Cited by 12
Alfadda, N. A., Aljuraiban, G. S., Awwad, H. M., Khaleel, M. S., Almaghamsi, A. M., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., & Alfadda, A. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.996004 · Cited by 9
“The links between NAFLD, metabolic syndrome, and T2D are probable due to the shared pathogenic factors (59).”
BackgroundVoudouris, D., Horianopoulou, M., Apostolopoulou, Z., Chryssanthopοulos, C., Bardopoulou, M., Maridaki, M. D., Vassilakopoulos, T., Koutsilieris, M., & Philippou, Α. (2023) · Metabolites · doi:10.3390/metabo13101074 · Cited by 8
“The identification of the factors related to the stages of the disease, from NAFLD to fibrosis to liver cirrhosis, is summed up in obesity, insulin resistance, type 2 diabetes, some features of the metabolic syndrome, and age as it progresses [3].”
BackgroundMuto, N., Oniki, K., Kudo, M., Obata, Y., Sakamoto, Y., Tokumaru, N., Izuka, T., Watanabe, T., Otake, K., Ogata, Y., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s217597 · Cited by 7
“sedentary lifestyle) in elderly populations.(7) Correspondence: Junji Saruwatari Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan Tel/Fax +81 96-371-4512 Email junsaru@gpo.”
BackgroundAlterations in the hepatocyte epigenetic landscape in steatosis
Maji, R. K., Czepukojc, B., Scherer, M., Tierling, S., Cadenas, C., Gianmoena, K., Gasparoni, N., Nordström, K. J. V., Gasparoni, G., Laggai, S., et al. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00504-8 · Cited by 7
Kim, K., Lee, Y., Lee, J. S., Kim, M. N., Kim, B. K., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Jung, I., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16755 · Cited by 9
Andrade, L. J. D. O., Guimarães, L. R., Cadete, R. B. F., Sodré, H. S., de Melo, P. R. S., & de Souza, E. C. (2015) · Brazilian Journal of Medicine and Human Health · doi:10.17267/2317-3386bjmhh.v3i2.653 · Cited by 6
“Beyond menopause, the prevalence of fatty liver rises sharply in women and exceeds that observed in their male counterparts.(18) In the present study, we showed that advanced age was positively associated with PS and NAFLD, and is compatible with the results of previous studies, possibly due to the age‐related decreas…”
ResultLee, Y.-S., Hwang, L., Hsu, H., & Tsou, M.-T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s302207 · Cited by 8
“With age-related decline in Kupffer cell deactivation of endotoxins and a slower, reduced ability to regenerate hepatocytes, fatty liver may progress to steatohepatitis and liver fibrosis.(49) Estrogen is believed to have antioxidant and antisteatotic effects in the liver through sensitization of Kupffer cells to toxi…”
BackgroundKinoshita, A., Onoda, H., Ueda, K., Imai, N., Iwaku, A., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2015) · Hepatology Research · doi:10.1111/hepr.12514 · Cited by 6
Old Age and Steatohepatitis: A Dangerous Liaison?
Vinciguerra, M. (2012) · Hepatology · doi:10.1002/hep.26212 · Cited by 6
Kim, J., Lee, S.-J., & Jee, Y. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01156-9 · Cited by 8
“These findings indicate that the prevalence of fatty liver disease is positively correlated with advancing age [56].”
Lin, F.-A., Hwang, L., Tsou, M.-T., & Huang, W.-H. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s425651 · Cited by 5
“The redistribution of body fat from subcutaneous tissue to visceral adipose tissue in older individuals has adverse metabolic effects, including hyperinsulinemia, hypertriglyceridemia, and low HDL-C levels, which are characteristic features of insulin resistance.(17) Most studies have suggested that low HDL-C levels h…”
BackgroundResultBrea, R., Valdecantos, M. P., Rada, P., Alén, R., García‐Monzón, C., Boscá, L., Fuertes‐Agudo, M., Casado, M., Martín‐Sanz, P., & Valverde, Á. M. (2021) · Aging · doi:10.18632/aging.202884 · Cited by 6
“binucleated cells, augmented lobular inflammation, and reduction in mitochondrial number [2, 44].”
BackgroundA review of hepatic fibrosis‐associated histopathology in aged cadavers
Mak, K. M., Kee, D. P., & Cheng, C. (2022) · The Anatomical Record · doi:10.1002/ar.24931 · Cited by 7
“…fatty liver disease (NAFLD)/steatohepatitis (NASH), and hepatitis C virus (HCV) infection (Floreani, 2007; Fox et al., 2011; Frith et al., 2009; Gan et al., 2011; Jansen, 2002; Martín-Carbonero et al., 2004; Noureddin et al., 2013), which are the most common chronic liver disorders among young…”
BackgroundIGUDESMAN, D. A., Mucinski, J. M., Harrison, S. L., Cawthon, P. M., Linge, J., Goodpaster, B. H., Cummings, S. R., Hepple, R. T., Jurczak, M. J., Kritchevsky, S. B., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae047 · Cited by 5
Ramírez‐Vélez, R., Izquierdo, M., García‐Hermoso, A., & Correa‐Rodríguez, M. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.04.004 · Cited by 6
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
Ezzat, W. M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i20.2633 · Cited by 5
“Epidemiological data also show a concerning age-related increase in NAFLD prevalence, starting from 3% in children to over 40% in individuals older than 70 years old[4].”
IGUDESMAN, D. A., Yu, G., Dauriat, C. J. G., Roman, T., Kashi, M. R., Blakley, E. A., Chassaing, B., & Corbin, K. D. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2024 · Cited by 4
“It affects (cid:1) 20% of adults aged 20 – 40 yr and 40% of adults aged 40 yr and older (2).”
Kinoshita, A., Hagiwara, N., Osawa, A., Akasu, T., Matsumoto, Y., Ueda, K., Saeki, C., Oikawa, T., Koike, K., & Saruta, M. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221077039 · Cited by 4
Rapamycin Reverses the Hepatic Response to Diet‐Induced Metabolic Stress That Is Amplified by Aging
Havas, A. P., Rajesh, A., Lei, X., Proulx, J. M., Miller, K. N., Field, A. E., Davis, A., Teneche, M. G., Gandhi, A., Lee, J., et al. (2026) · Aging Cell · doi:10.1111/acel.70395 · Cited by 3
Song, W., Wu, N., Li, X., Li, D., Li, J., Liu, S. H., Ma, Q., Yue, Z. D., Zhu, X., & Yajuan, Q. I. (2026) · Aging Cell · doi:10.1111/acel.70541 · Cited by 3
Ravindran, R., Jaganathan, R., & Kalaiselvi, P. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3490 · Cited by 3
“All these changes together affect the morphology and oxidative capacity of liver.(6,7) In humans, an increased plasma low density lipoprotein (LDL)cholesterol level is found to be strongly associated with aging.”
BackgroundShin, S., Lee, J.-Y., Bae, H. R., Park, H.-J., & Kwon, E. (2024) · Nutrition Research and Practice · doi:10.4162/nrp.2024.18.1.46 · Cited by 3
“Hepatic steatosis is associated with age-related chronic liver diseases, and its primary characteristic is fat accumulation within liver cells [6].”
BackgroundTutunchi, H., Saghafi‐Asl, M., Hosseinzadeh‐Attar, M. J., Jafarabadi, M. A., & Ostadrahimi, A. (2020) · doi:10.21203/rs.3.rs-15574/v1 · Cited by 3
“Several studies have demonstrated that NAFLD is more prevalent among men and elderly people (46).”
BackgroundZhang, T., Huang, G., Wang, T., Chen, J., Zhou, X., & Shi, W. (2023) · medRxiv · doi:10.1101/2023.10.01.23296398 · Cited by 4
“of aging pigments at the cytoplasm (40,41).”
Deep learning for non-invasive NAFLD detection and staging: A comprehensive review
Sengar, P., Singh, J., & Bansal, A. (2026) · Journal of Liver Transplantation · doi:10.1016/j.liver.2026.100318 · Cited by 3
Metadata
- Authors
- Gan, L., Chitturi, S., & Farrell, G. C.
- Affiliations
- Australian National University (AU)
- Corresponding author
- Farrell, Geoffrey C.
- ORCID
- Chitturi, Shivakumar
- Venue
- Current Gerontology and Geriatrics Research
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-12
- ISSN
- 1687-7063 (ISSN-L)
- 1687-7071
- PMC
- PMC3171768
- OpenAlex
- W2023535895
- Cited by
- 135
- References
- 127
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 13 · 2023: 14 · 2022: 11 · 2021: 13 · 2020: 12 · 2019: 12 · 2018: 7 · 2017: 6 · 2016: 5 · 2015: 11 · 2014: 2 · 2013: 6 · 2012: 5
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Current Gerontology and Geriatrics Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ANU Open Research (Australian National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, aging, older adults, hepatic steatosis, nonalcoholic steatohepatitis, liver cirrhosis, hepatocellular carcinoma, type 2 diabetes, insulin resistance, metabolic abnormalities, mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.